Biotech

All Articles

Sanofi's $80M bank on Key dystrophy medicine finishes in period 3 crash

.Merely 4 months after Sanofi bet $80 million in beforehand money on Fulcrum Rehabs' losmapimod, the...

Oncternal share sinks 60% surrounded by layoffs, test discontinuations

.Cancer company Oncternal Therapies is actually folding all its own clinical trials and also giving ...

Roche is actually keeping out chances that its injectable being overweight prospect could inevitably show 25% weight management in late-stage trial

.Roche is holding out hopes that its injectable being overweight possibility might eventually displa...

Novo Nordisk hails 'exceptional' fat burning lead for dual-acting oral medicine in very early test

.Novo Nordisk has raised the top on a period 1 trial of its oral amylin and also GLP-1 receptor co-a...

AbbVie sues BeiGene over blood stream cancer medication trade secrets

.Just a few quick full weeks after winning an FDA Fast lane tag for its own investigational BTK degr...

Lilly provides one-two punch along with 2nd tranche of positive records on once a week insulin candidate

.Soon after a good records drop for Eli Lilly's efsitora alfa, the Indianapolis-based business is ag...

BridgeBio cuts gene therapy spending plan as clinical data dissatisfy

.BridgeBio Pharma is actually lowering its genetics treatment spending plan and also drawing back co...

GSK submits HSV injection wishes after phase 2 stop working, signing over race to Moderna, BioNTech

.GSK's try to develop the first vaccination for herpes simplex virus (HSV) has finished in failing, ...

GSK's long-acting breathing problem medicine halved strikes in stage 3

.GSK's long-acting breathing problem therapy has actually been presented to cut in half the number o...

AstraZeneca, Daiichi unbox Dato-DXd's overall survival stop working

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually n...